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Multidisciplinary team approach in breast cancer: a 
nationwide survey in Korea
Byung Joo Chae, Ja Seong Bae, Byung Joo Song, Sang Seol Jung
Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
Purpose: This assesses the current workings of multidisciplinary team (MDT) meetings across Korea through surgeons’ re-
ports and their current commitments to MDT meetings pertaining to breast cancer, and to determine any perceived areas of 
potential improvement. Methods: A questionnaire was sent out to 307 members of The Korean Breast Cancer Society (KBCS) 
who worked at comprehensive or university medical centers in Korea. The mailing lists of the KBCS members were obtained 
with the approval of the society. From December 2008 to February 2009, the survey was distributed by surface and electronic 
mail, with an initial mailing followed by another distribution to non-responders eight weeks later. Results: Sixty-five in-
dividuals (21.2%) returned the completed survey. Of these, 38 responders (62.3%) participated in MDT meetings. Most 
(97.4%) breast health specialists regarded MDT meetings as an effective method for treatment planning. Most responders 
(94.7%) reported that the MDT leader was a breast surgeon. Conclusion: The MDT approach is perceived as an effective 
method for breast cancer treatment planning and is a feature in most major centers in Korea. Further work is needed to en-
sure that the MDT approach operates as intended and that all breast cancer patients have access to an MDT.
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INTRODUCTION
A breast physician is a medical practitioner with special 
training in the diagnosis and management of breast 
disease. This relatively small group of specialized clini-
cians has a unique and constantly expanding role in multi-
disciplinary breast teams in Korea. The importance of the 
team approach is well-known and in the field of breast 
cancer there is evidence that patients cared for by a multi-
disciplinary team (MDT) rather than a series of individual 
practitioners have an improved survival 10 years follow-
ing diagnosis [1]. National and international clinical prac-
tice guidelines [2] endorse multidisciplinary care as the 
preferred approach to manage breast cancer. However, 
few studies have looked at how these guidelines are fol-
lowed by the medical community. Also, the definition of 
MDT varies both in the literature [3,4] and among health 
professionals, with no one interpretation being a perfect fit 
for all situations.
A recent report [3] described that surgery, chemo-
therapy and hormonal therapy are the most common 
treatment options for women, thus requiring input from a Breast cancer care in Korea
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Table 1. Summary of responder characteristics
Characteristic No.
Age (yr)
  31-40 24
  41-50 17
  51-60 19
  ≥61 5
Gender
  Male 48
  Female 17
Hospital volume (bed)
  ＜500 11
  500-1,000 38
  ＞1,000 16
Affiliation
  Surgeon 57
  Medical oncologist 1
  Other 7 
Experience of breast cancer (yr)
  ＜5 16
  5-10  17
  10-15  8
  ＞15 23
  No answer 1
New patients per year
  ＜100 32
  100-200 17
  200-400 8
  ＞400 4
  No answer 3
variety of breast cancer specialists during treatment 
planning. Care provided by an MDT is thought to offer pa-
tients the most appropriate evidence-based care as man-
agement plans are based on a broad range of expert 
knowledge [4]. Improvements in communication and de-
cision-making among health professionals in coordina-
tion of care for their patients are other potential benefits. 
However, the outcomes of the MDT approach have not 
been rigorously evaluated and evidence from published 
empirical studies and reports on any benefit is limited 
[4,5].
This study aimed to assess the current workings of MDT 
meetings throughout Korea through surgeons’ reports 
and their current commitments to MDT breast meetings, 
and to determine any perceived areas where there was po-
tential for improvement.
METHODS
A questionnaire was sent out to 307 members of The 
Korean Breast Cancer Society (KBCS) who worked at com-
prehensive or university medical centers in Korea. The 
mailing lists of the KBCS members were obtained with the 
approval of the society. From December 2008 to February 
2009, the survey was distributed by surface and electronic 
mail, with an initial mailing followed by another dis-
tribution to non-responders eight weeks later. MDT was 
defined with different specialists working as teams coop-
eratively with each other and their patients to diagnose, 
treat and mange breast cancer. The questionnaire was 
comprised of an introductory cover letter in which the 
purpose of the survey was indicated; a section soliciting 
general information from the responder regarding gen-
der, age, hospital volume, affiliation of the department 
and experience with breast cancer treatment; and the main 
portion that solicited MDT information including use/ 
non-use of the approach, membership structure, schedule 
of meetings, contents of meetings and opinions concern-
ing the MDT approach in the treatment of breast cancer.
RESULTS
Responder analysis
About 21% (65/307) of KBCS members who were con-
tacted completed and returned the survey. Forty-nine of 
the 90 institutions (52.1%) that were contacted partici-
pated in this survey. Most responders were male (48/65) 
and worked at hospitals with more than 500 beds (54/65). 
Fifty-seven of 65 responders (88%) belonged to the 
Department of Surgery, one to the Department of Medical 
Oncology, and seven to other departments. Forty-eight 
responders (75%) had more than 5 years experience in 
managing breast cancer patients (Table 1).
Subject of follow-up management
Most commonly (95%), follow-up involved the Depart-
ment of Surgery with or without adjuvant chemotherapy. 
When adjuvant chemotherapy was included, surgeon fol-Byung Joo Chae, et al.
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Table 2. Follow-up management for the 65 patients without 
chemotherapy
No. (%)
Surgery 57 (87.7)
Medical oncology   3 (4.6)
Initial visit   0 (0)
No response   5 (7.7)
Fig. 1. (A) Are you participating in multidisciplinary team (MDT) meetings? (B) What members participate in your MDT meeting? (C) Who 
is the leader of your MDT? (D) How many times per month is your MDT? APN, advanced practice nurse. 
low-up occurred in 76% of the cases. Ninety-five percent 
of patients receiving hormonal therapy were followed up 
at the Department of Surgery (Table 2).
MDT approach
Thirty-eight of the 61 responders (62.3%) participated in 
MDT meetings. Of these, 23 responders (37.7%) had not 
participated in MDT meetings, but felt that the approach 
was valuable and necessary for improved patient care 
(Fig. 1A).
Concerning team structure, most MDT s consisted of 
breast surgeons, medical oncologists, radiologists, pathol-
ogists and radiation oncologists. A few teams also in-
cluded psychiatrists and other support members (Fig. 1B). 
The largest number of responders (94.7%) reported that 
the MDT leader was a breast surgeon (Fig. 1C).
A relatively even distribution was evident in the re-
sponses concerning the frequency of MDT meetings. Of 
the 38 MDT meeting participants, 13 attended more than 
one meeting a week, with the meeting schedule being ir-
regular for seven respondents (Fig. 1D). Almost all newly 
diagnosed patients, most postoperative patients and re-
curring cases were discussed in MDT meetings and a small 
number of patients with benign disease were discussed Breast cancer care in Korea
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Fig. 2. (A) What are subjective cases in your multidisciplinary team 
(MDT)? (B) What are the contents of your MDT? (C) What do you 
think about the effectiveness of MDT?
(Fig. 2A). The discussion of pathology results, radiologic 
review of disease, surgical findings and appropriate treat-
ment plan were almost always part of a case discussion 
(Fig. 2B). In comparison, relevant psychosocial issues were 
discussed in only 2.1% of the meetings.
Clinicians’ views regarding the effectiveness of their 
MDT meetings in optimizing treatment recommendations 
are summarized in Fig. 2C. Thirty-seven of the 38 re-
spondents regarded the meetings as effective. The re-
spondents opined that MDT meetings allowed for a good 
contact between disciplines, improved referrals, facili-
tated collaborative efforts and enabled patients to receive 
the most current treatment. The robust discussions within 
meetings were seen as beneficial as they facilitated stand-
ardization of treatment and a consensus treatment plan. 
Respondents also indicated factors that inhibited 
effectiveness. These included delayed decision, increased 
time and manpower, time limitation, confusion, gain and 
loss among departments and difficulty in managing many 
patients.
DISCUSSION
Presently, the vast majority (97.4%) of breast health spe-
cialists regarded MDT meetings as an effective method for 
treatment planning and believed that these meetings re-
sult in substantial improvements in care for women with 
breast cancer. The majority of respondents who do not cur-
rently participate in MDT meetings (95.6%) regard them 
as valuable and necessary. 
Large numbers of surgeons, oncologists, pathologists 
and radiation oncologists regularly attend MDT meetings 
in Korea. Most often, the meetings are led by a breast 
surgeon. Although most respondents (95%) described that 
follow-up involved the Department of Surgery with or 
without adjuvant chemotherapy, the high level of attend-
ance for medical oncologists was particularly noteworthy 
given that international audits of MDT functionality con-
sistently reveal that medical oncologists are least likely to 
attend the meetings, of all medical specialists [6,7]. This is 
not surprising, however, given that most oncologists in 
our sample were based in comprehensive or university Byung Joo Chae, et al.
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cancer centers where oncology services are most com-
monly available.
Presently, the presence of psychologists in MDTs was 
limited despite clinical practice guidelines [2] highlighting 
the importance of psychosocial care for cancer patients 
and the well-documented elevated levels of psychosocial 
morbidity and unmet emotional and supportive care 
needs associated with diagnosis and treatment of breast 
cancer [8,9]. Also, there was a low level of participation by 
other support personnel such as data managers, coor-
dinators and social workers. Psychosocial issues were not 
discussed in the majority of responses, yet it is not possible 
to tell from this data whether links to psychosocial services 
were in place outside of the meeting.
All newly diagnosed breast cancer patients were dis-
cussed in 45% of MDT meetings, a figure less than 60 to 
94% noted in studies from the United Kingdom [6,7]. 
Discussion of benign cases was infrequent (8% of cases). 
The schedule, content and composition of MDT meet-
ings varied in the responding institutions. Some meetings 
were less likely to discuss all patients. Some meetings had 
a less frequent schedule or were informal, to the point of 
personal communication between several participants be-
ing regarded as an MDT. 
The main limitation of our study was that most res-
ponders (57/66) were surgeons. So, our results could not 
show opinions of all MDT members. While it is acknowl-
edged that there may be a bias in reporting of self-attend-
ance by those completing the survey, this study was con-
ducted with an adequate sampling strategy for a relatively 
large objective. This national study is the first to ascertain 
the involvement of breast cancer specialists in MDT treat-
ment planning meetings in Korea. It has also provided an 
insight into MDT meeting structure and format.
Sometimes there is no discussion with a patient prior to 
the operation. This falls outside current international 
recommendations. There is a need for more detailed ad-
vice with regard to organization and running of MDTs to 
ensure that all patients with breast cancer can reap the po-
tential benefits of having all aspects of their management 
discussed at appropriately staffed MDTs. 
The MDT approach in breast cancer does have draw-
backs that include delayed decision making, allocation of 
increased time and more manpower, time limitation, con-
fusion, gain and loss among departments and difficulty in 
managing numerous patients. However, the addition of a 
breast physician to the team has advantages for all team 
members and for the patient. A breast physician can en-
hance the continuity of care and communication between 
team members. Working in partnership with a breast 
physician may be of particular benefit to the breast sur-
geon, allowing the surgeon to focus on newly diagnosed 
cancer patients and patients with benign disease who re-
quire surgery [10].
In conclusion, the majority of health professionals re-
gard MDT meetings as an effective method for treatment 
planning and a relatively active MDT approach exists in 
most major centers in Korea. Further work is needed to en-
sure that MDTs function and co-operate as intended, and 
that all breast cancer patients have access to an MDT.
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